Early prediction of death in acute hypertensive intracerebral hemorrhage
- Authors:
- Published online on: November 25, 2015 https://doi.org/10.3892/etm.2015.2892
- Pages: 83-88
-
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Although the incidence of hypertensive intracerebral hemorrhage (HICH) has declined recently, the disability rate and mortality at long-term follow up thereof are on the increase (1). Previous clinical report findings showed that the mortality rate of intracerebral hemorrhage (ICH) was 34–43.9% at 90 days follow-up (2) and 47% after 1 year (3). Effective management of acute ICH, particularly its poor prognosis, requires a profound understanding of risk factors involved, including age, volume and location of hematoma, extension to intraventricular hemorrhage or not, blood sugar, blood pressure (BP), temperature and consciousness (4–6). It is important to identify early warning signals of death of HICH and take proactive interventions.
The present study aimed to examine key risk factors that provided early prediction of death, with the aim of early intervention to reduce mortality. The medical records of 128 HICH patients admitted to the Department of Xuzhou Central Hospital (Xuzhou, China) were retrospectively examined. Association of mortality and survival with age, BP, hematoma volume and neurological scores of the patients were analyzed.
Materials and methods
Patient information
A total of 128 patients, aged ≥18 years, had spontaneous ICH confirmed by computed tomography (CT) within 6 h onset and elevated systolic BP ≥150–220 mmHg. Inclusion criteria for the study were: ≥18 years of age, spontaneous HICH within 6 h confirmed by CT, and elevated systolic BP of ≥150 mmHg. Exclusion criteria for the study were: clear evidence that the HICH was secondary to a structural cerebral abnormality (e.g., arteriovenous malformation, intracranial aneurysm, or tumour) or under treatment with the use of a thrombolytic agent, or with a pre-planned decompressive neurosurgical intervention.
Analyses of clinical records
BP recordsBP was recorded for each patient at the following time points: i) emergency, ii) admission, ii) once every 6 h during the first 24 h after admission, and iv) twice per day after 24 h and within 1 week.
Measurement of hematoma volumeStandard CT scanning was performed at admission, and at 24±3 h after admission. Hematoma volume was measured manually by the ABC/2 method using Philip Brilliance 64-slice CT (Philips Medical Systems, Eindhoven, The Netherlands).
Neurological deficit scoringThe neurological functions of the patients were evaluated at admission, 24 h after admission, 1 week after admission or discharge using the Glasgow Coma Scale (GCS), National Institutes of Health Stroke Scale (NIHSS) scoring scale.
Evaluation of neurological function recoveryThe modified Rankin scale (mRS) was utilized to assess the neurological function recovery state of the patients after stroke (grading scores, 0–6). The scores used were: 0, no symptoms at all; 1, with symptoms but without obvious disabilities, able to complete all of their normal duties and day-to-day activities; 2, mild disability, failed to complete all of their normal duties and activities, but were able to handle their personal business without external assistance; 3, moderate disability, some assistance required, albeit able to walk by themselves; 4, severe disability, unable to walk without assistance or carry out daily functions; 5, complete disability, completely bedridden, suffer from gatism, and requiring continuous care and nursing; 6, death. The mRS scores were recorded at follow up on day 28 and 90.
Statistical analysisStatistical analysis was performed using SPSS 19 software (IBM Corp., Armonk, NY, USA). Numerical data were subjected to the Kolmogorov-Smirnov normality test. Normal distribution was assessed using the t-test, and abnormal distribution was detected using the non-parametric rank sum test (Wilcoxon two-sample test). Ranked data were analyzed by the Chi-square test. Correlation and independent risk factors of death were analyzed by calculating the correlation index and logistic binary regression using Spearman's correlation.
Results
Patient characteristics
The average age of the patients included in the present study was 64.28±14.04 years. The results showed that of the 128 subjects studied, 15 patients succumbed within 90 days and the mortality of HICH was 11.7%. Of the 15 patients, 1 succumbed within 24 h, accounting for 6.7% of the total death toll, while 6 patients succumbed within 1 week, accounting for 40% of the total death toll. The remaining 8 patients succumbed between 1 week and 90 days. The average age for these patients was 64.28±14.04 years.
Clinicopathological characteristics and mRS scores
Clinical characteristics such as age, gender, hematoma volume and location, and BP at different time points were analyzed for patients that succumbed as well as survivors (Table I). Mortality was closely associated with age (P<0.001) although not with gender. Mortality was significantly associated with BP at 30 min, 45 min and 6 h after admission (P<0.05), although not on admission 180.33±17.17 vs. 174.72±16.13 mmHg (P=0.211). Mortality was also associated with hematoma volume but not with the location. The average age of patients who succumbed was significantly higher than that of the survivors (75.53 vs. 62.79 years, P=0.001). Higher mRS scores, signifying worse recovery of neurological functions following cerebral hemorrhage, were primarily found in senior patients aged over 64.25 years (r=0.375, P<0.001. Fig. 1). By contrast, the effect of gender on the mRS score was not significant.
Systolic BP
The systolic pressure of the HICH patients was monitored for 1 week after admission or up to death (Fig. 2). The results showed that the BP for patients who died versus those who survived during our observation period was similar at emergency (181.87±18.30 vs. 184.39±18.65 mmHg) and on admission (180.33±17.17 vs. 174.72±16.13 mmHg). However, a significant difference was observed for BP between patients who died and survivors measured at 30 min, 45 min and 6 h (Table I and Fig. 2).
GCS and NIHSS scores
The results revealed that death was associated with the hematoma volume following onset and within 24 h, but was irrelevant to the hematoma location (P>0.05) (Table II). Death occurring during 90 days was irrelevant to the NIHSS score on admission, but relevant to the neurological score within 24 h and 7 days after admission (Table III). The average GCS scores were 9.29±4.07 vs. 12.76±2.25 and 9.56±3.40 vs. 13.42±2.26 for patients who died within 24 h and 1 week, respectively. The NIHSS score for patients who died were 19.00±10.88 vs. 10.20±8.08 and 23.56±12.98 vs. 8.39±8.22 within 24 h and 1 week, respectively.
Results from the multifactor regression analysis revealed that of the risks factors examined, age and hematoma volume were independent predictors of death [age odds ratio (OR)=1.082, 95% confidence interval (CI): 1.018–1.149, p=0.011; hematoma volume OR=1.011, 95% CI: 1.000–1.023, p=0.046].
Discussion
The aim of the present study was to investigate early warning signals of death in patients with acute HICH. Of the 128 patients with acute HICH included in this study, mortality was 0.8% within 24 h, 4.7% within 1 week, increasing to 11.7% in the follow up at 90 days Mortality was irrelevant to gender, but closely relevant to age. The average ages of the dead and surviving patients were 75.53±15.18 vs. 62.79±13.25 (p<0.05). This result indicated that the older the patients, the higher the mortality, which was consistent with literature reports showing patients >75 had a higher mortality (7). An increase in age leads to degeneration of the function of tissues and organs within the body, thus, compensation ability becomes exacerbated. As for the blood vessel itself, the vascular wall of elderly patients was more vulnerable to degenerative changes: their lipid became hyaline-degenerated, fibrous protein became necrotic, and segmental aortic structure was broken, in such a manner that their vascular compliance became exacerbated (5). These degenerative changes contributed to high mortality of acute HICH in senior patients.
High BP was an important factor that affected the onset and prognosis of cerebral hemorrhage. However, at which point BP should be regulated remains controversial (8–10).
Baños-González et al reported poor prognosis for cerebral hemorrhage patients with too low or too high systolic pressure, and it was preferable to maintain the BP at 100–159 mmHg (11). If the BP for acute HICH patients with onset within 6 h was proactively under control at an early stage, particularly if the 1-h systolic pressure was within 140 mmHg, patients had a better clinical prognosis than those following the conventional depressurization standard protocol (>180 mmHg) (13). By contrast, our data showed that high systolic BP recorded, following emergent treatment (184 mmHg) and on admission (175 mmHg) (P=0.772 and P=0.375, respectively), was not significantly correlated with death for the HICH patients. It is possible that the BP in patients with acute cerebral hemorrhage increased temporarily, however, the level of BP at this point was not influences at the 90-day prognosis of patients.
Tetri et al (13) reported that despite their higher BP values at admission, subjects with untreated hypertension showed improved survival and more frequently favorable outcome after BP-lowering therapy than other patients The findings may be attributed to the young age of their recruited patients and did not have cardiovascular and cerebrovascular diseases, history of anticoagulant drugs and diabetes mellitus. In this case, the level of BP following admission may not provide early warning to the prognosis of cerebral hemorrhage. Such findings were consistent with the results of our study. Our study also found that patients who died had significantly higher BP at 30, 45 and 60 min after admission than those survived (all P<0.05). The higher the BP was, the higher the mortality was (r=0.263, p=0.003). Therefore, regulation of BP within 6 h after admission was crucial. From 6 to 24 h after admission, BP was controlled at 143.21±17.76. Other studies on the safety of early active antihypertensive therapy on acute HICH also demonstrated similar findings (12,14–16). If BP was proactively reduced at an early stage, hematoma enlargement within 24 h could be controlled, and consequently clinical prognosis could be improved.
The results of the present study have shown that mortality was closely associated with the volume of hematoma following onset and 24 h after onset, but irrelevant to the hematoma location. We performed binary logistic regression analysis on age, gender, hematoma volume on admission, level of consciousness and BP, and found that age and hematoma volume were independent risk factors of death. The larger the hematoma volume was, the higher the mortality was. This result was consistent with previous findings (17). Methods that may intervene in the enlargement of hematoma include BP adjustment, encephaledema and relieving of intracranial hypertension, surgical resection, anticoagulant therapy and hemostasis therapy (18,19). A systematic review (20) identified that ventricular drainage combined with defibrinogen therapy on patients with extension to ventricles effectively prevents hydrocephalus and improves patient quality of life. Previous findings have shown that conservative treatment by operation and medications had no difference on the short-term outcomes for young and elderly patients with cerebral hemorrhage. However, in the long term, the prognosis of operative treatment on the youth was better than those receiving conservative treatment (21).
The GCS and NIHSS scores identified on admission were not significantly correlated with death. This result indicated that the level of consciousness on admission was not predictive of death. However, mortality was relevant to the neurological score recorded at 24 h and 1 week after admission. If the GCS score was <9, the NIHSS scores were >19 and >24 within 24 h and 1 week, respectively, high mortality was observed (data not shown; GCS: 12±3, r=-0.622; NIHSS: 11±8, r=0.707). Disturbance of consciousness on admission was one of the most important factors for death of cerebral hemorrhage (3,22). However, the level of consciousness is likely to be influenced by a hematoma spot (supratentorial or subtentorial), hematoma volume, with extension to ventricles or not, and the time from onset to admission (23). In particular, hematoma occurring in the brain stem affected the ascending reticular activating system, and thus influenced the level of consciousness, resulting in somnolence and coma. Additionally, larger hematoma may cause more obvious mass effect, leading to more severe subsequent hematoma. These factors may also affect the level of patient consciousness, which may explain the reason for the consciousness level not clearly predicting death.
In conclusion, the results of the present study have shown that patient age and hematoma volume were independent risk factors of death of acute HICH, and may serve as important early warning signals for cerebral hemorrhage. Proactive control and management of hematoma may reduce the mortality of HICH.
References
Zhang Y, Yi B, Ma J, Zhang L, Zhang H, Yang Y and Dai Y: Quercetin promotes neuronal and behavioral recovery by suppressing inflammatory response and apoptosis in a rat model of intracerebral hemorrhage. Neurochem Res. 40:195–203. 2015. View Article : Google Scholar : PubMed/NCBI | |
Sia SF, Tan KS and Waran V: Primary intracerebral haemorrhage in Malaysia: in-hospital mortality and outcome in patients from a hospital based registry. Med J Malaysia. 62:308–312. 2007.PubMed/NCBI | |
Nilsson OG, Lindgren A, Brandt L and Säveland H: Prediction of death in patients with primary intracerebral hemorrhage: A prospective study of a defined population. J Neurosurg. 97:531–536. 2002. View Article : Google Scholar : PubMed/NCBI | |
Chen HS, Hsieh CF, Chau TT, Yang CD and Chen YW: Risk factors of in-hospital mortality of intracerebral hemorrhage and comparison of ICH scores in a Taiwanese population. Eur Neurol. 66:59–63. 2011. View Article : Google Scholar : PubMed/NCBI | |
Stein M, Luecke M, Preuss M, Boeker DK, Joedicke A and Oertel MF: Spontaneous intracerebral hemorrhage with ventricular extension and the grading of obstructive hydrocephalus: the prediction of outcome of a special life-threatening entity. Neurosurgery. 67:1243–1251; discussion 1252. 2010. View Article : Google Scholar : PubMed/NCBI | |
Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K and Steiner T: Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators: Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 66:1175–1181. 2006. View Article : Google Scholar : PubMed/NCBI | |
Zia E, Engstrom G, Svensson PJ, et al: Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage. Stroke. 40:3567–3573. 2009. View Article : Google Scholar : PubMed/NCBI | |
Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, et al: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 30:905–915. 1999. View Article : Google Scholar : PubMed/NCBI | |
Bath P, Chalmers J, Powers W, Beilin L, Davis S, Lenfant C, Mancia G, Neal B, Whitworth J and Zanchetti A: International Society of Hypertension Writing Group: International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens. 21:665–672. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hanger HC, Wilkinson T, Keeling S and Sainbury R: New Zealand guideline for management of stroke. N Z Med J. 117:U8632004.PubMed/NCBI | |
Baños-González M, Cantú-Brito C, Chiquete E, Arauz A, Ruiz-Sandoval JL, Villarreal-Careaga J, Barinagarrementeria F and Lozano JJ: Systolic blood pressure and functional outcome in patients with acute stroke: a Mexican registry of acute cerebrovascular disease (RENAMEVASC). Arch Cardiol Mex. 81:169–175. 2011.(In Spanish). PubMed/NCBI | |
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, et al: INTERACT2 Investigators: Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 368:2355–2365. 2013. View Article : Google Scholar : PubMed/NCBI | |
Tetri S, Huhtakangas J, Juvela S, Saloheimo P, Pyhtinen J and Hillbom M: Better than expected survival after primary intracerebral hemorrhage in patients with untreated hypertension despite high admission blood pressures. Eur J Neurol. 17:708–714. 2010. View Article : Google Scholar : PubMed/NCBI | |
Tsivgoulis G, Katsanos AH, Butcher KS, Boviatsis E, Triantafyllou N, Rizos I and Alexandrov AV: Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis. Neurology. 83:1523–1529. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gould B, McCourt R, Gioia LC, Kate M, Hill MD, Asdaghi N, Dowlatshahi D, Jeerakathil T, Coutts SB, Demchuk AM, et al: ICH ADAPT Investigators: Acute blood pressure reduction in patients with intracerebral hemorrhage does not result in borderzone region hypoperfusion. Stroke. 45:2894–2899. 2014. View Article : Google Scholar : PubMed/NCBI | |
Grise EM and Adeoye O: Blood pressure control for acute ischemic and hemorrhagic stroke. Curr Opin Crit Care. 18:132–138. 2012. View Article : Google Scholar : PubMed/NCBI | |
Arima H, Wang JG, Huang Y, Heeley E, Skulina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, et al: INTERACT Investigators: Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology. 73:1963–1968. 2009. View Article : Google Scholar : PubMed/NCBI | |
Steiner T and Bösel J: Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke. 41:402–409. 2010. View Article : Google Scholar : PubMed/NCBI | |
Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, et al: INTERACT Investigators: Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 41:307–312. 2010. View Article : Google Scholar : PubMed/NCBI | |
Nieuwkamp DJ, de Gans K, Rinkel GJ and Algra A: Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 247:117–121. 2000. View Article : Google Scholar : PubMed/NCBI | |
Koivunen RJ, Satopää J, Haapaniemi E, Strbian D, Meretoja A, Mustanoja S, Silvennoinen H, Salonen O, Niemelä M, Tatlisumak T, et al: Predictors of early mortality in young adults after intracerebral hemorrhage. Stroke. 45:2454–2456. 2014. View Article : Google Scholar : PubMed/NCBI | |
el Chami B, Milan C, Giroud M, Sautreaux JL and Faivre J: Intracerebral hemorrhage survival: French register data. Neurol Res. 22:791–796. 2000.PubMed/NCBI | |
Fan JS, Huang HH, Chen YC, Yen DH, Kao WF, Huang MS, Huang CI and Lee CH: Emergency department neurologic deterioration in patients with spontaneous intracerebral hemorrhage: Incidence, predictors, and prognostic significance. Acad Emerg Med. 19:133–138. 2012. View Article : Google Scholar : PubMed/NCBI |